Yu Miura
Hidaka, 3501298, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers.
Journal: Current oncology (Toronto, Ont.)
Published: January 07, 2026
Early FMISO PET changes as exploratory predictors of immune checkpoint inhibitor response in advanced lung cancer: a pilot study.
Journal: Scientific reports
Published: November 05, 2025
Th7R predicts chemo-immunotherapy response and survival in small cell lung cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: August 29, 2025
Efficacy and Safety of First-Line Nivolumab Plus Ipilimumab in Patients with Postoperative Recurrent and Inoperable Non-Small Cell Lung Cancer: A Real-World Retrospective Observational Study.
Journal: Medicina (Kaunas, Lithuania)
Published: March 21, 2025
Durvalumab after concurrent chemoradiotherapy for sensitizing epidermal growth factor receptor-mutant stage III non-small cell lung cancer: A Japanese Real-World data analysis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 09, 2025
Prognostic biomarkers for extensive-stage small cell lung cancer receiving amrubicin following failure of chemoimmunotherapy: a retrospective cohort study.
Journal: Translational lung cancer research
Published: February 26, 2025
Prognostic relevance of TROP2 expression in patients with non-small cell lung cancer receiving immunotherapy.
Journal: Scientific reports
Published: February 26, 2025
Correlation between T cell immunity and the duration of EGFR-TKI resistance acquisition in patients harboring EGFR mutations.
Journal: Cancer immunology, immunotherapy : CII
Published: February 05, 2025
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer.
Journal: Journal of cancer research and clinical oncology
Published: December 04, 2024
Concurrent Onset of Osimertinib-Induced Heart Failure and Metronidazole-Induced Encephalopathy During Brain Abscess Treatment: A Report of a Rare Case.
Journal: Cureus
Published: December 03, 2024
Metabolic tumor volume on 18F-FDG uptake as a negative predictor after ipilimumab plus nivolumab in advanced non-small cell lung cancer.
Journal: Translational lung cancer research
Published: November 14, 2024
Last Updated: 09/26/2026